Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FVGTZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,202
Award facts
- Contract value 100% obligated
- $19,202.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors with a ceiling value of $19,202.22. The contract, executed on October 27, 2025, with an ultimate completion date of October 28, 2025, utilizes firm fixed pricing under a competitive, non-set-aside arrangement. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 vehicle running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for the Defense Health Agency and military healthcare systems. The company's extensive federal contract portfolio demonstrates consistent capability in delivering brand-name medications, generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains through competitive procurement. The award of this Dupixent delivery order reflects AmerisourceBergen's established standing as a reliable supplier within DLA's medical supply chain and its role supporting pharmaceutical needs across the Department of Defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DB26FVGTZ?
SPE2DB26FVGTZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FVGTZ worth?
The government has obligated $19,202 on SPE2DB26FVGTZ.
Is contract SPE2DB26FVGTZ an order under another contract?
Yes. SPE2DB26FVGTZ is a delivery order under SPE2DB25D3017, an indefinite delivery contract.
Was contract SPE2DB26FVGTZ competed?
The extent of competition for SPE2DB26FVGTZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award